Nuberg Wins Chlor-alkali Project in India

Indian chemical plant contractor Nuberg EPC has been tapped to build a 250 t/d chlor-alkali plant planned by Indian chemical major Chemfab Alkalis at Karaikal, Puducherry.

The project, for which no investment cost nor contract value have been announced, is expected to be completed in 22 months. It will be the engineering firm’s first greenfield caustic soda project delivery in India.

Nuberg said it is taking on the project under an Engineering, Procurement, and Construction Management (EPCM) service-based contract.

The facility will use the latest bi-polar membrane based electrolysis system technology, Bipolar Membrane Cell Technology Electrolyzer. With this, the contractor said, production can be easily upgraded to the latest developments in future. Moreover, the plant will need little maintenance.

At Karaikal, Chemfab Alkis will produce caustic soda, hydrochloric acid, sodium hypochlorite, anhydrous sodium sulphate and soda ash lye that will be used by the textile, aluminum, paper and pulp sectors as well as water industries.

Author: Dede Williams, Freelance Journalist

The project will be Nuberg EPCs first greenfield Caustic Soda project delivery...
The project will be Nuberg EPC's first greenfield Caustic Soda project delivery in India. © Nuberg EPC

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.